{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:55:41Z","timestamp":1776495341104,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1245\/s10434-024-15639-5","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T20:08:44Z","timestamp":1720901324000},"page":"5483-5486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Surgical Perspectives on the Updated ASTRO Guideline on Partial Breast Irradiation for Breast Cancer"],"prefix":"10.1245","volume":"31","author":[{"given":"K. U.","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayna L.","family":"Showalter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick M.","family":"Dirbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Society of Surgical Oncology Breast Disease Site Work Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Laronga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen","family":"Agnese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miral","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea V.","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Botty van den Bruele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick M.","family":"Dirbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwadamilola M.","family":"Fayanju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shicha","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toan T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko Un","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Plichta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayna","family":"Showalter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Tranakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashlee A.","family":"Woodfin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,13]]},"reference":[{"issue":"2","key":"15639_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.prro.2023.11.001","volume":"14","author":"SF Shaitelman","year":"2023","unstructured":"Shaitelman SF, Anderson BM, Arthur DW, et al. Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an astro clinical practice guideline. Pract Rad Oncol. 2023;14(2):112\u201332.","journal-title":"Pract Rad Oncol"},{"key":"15639_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.3759","author":"OD Gentilini","year":"2023","unstructured":"Gentilini OD, Botteri E, Sangalli C, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial [Internet]. JAMA Oncol. 2023. https:\/\/doi.org\/10.1001\/jamaoncol.2023.3759.","journal-title":"JAMA Oncol"},{"key":"15639_CR3","unstructured":"SSO Choosing Wisely: Five Things Physicians and Patients Should Question [Internet]. Choosing Wisely [cited 2024 Apr 16] Available at: https:\/\/www.surgonc.org\/wp-content\/uploads\/2024\/04\/FINAL_Choosing_Wisely_5.30.23-SSO-5things-List_2021-Updates.pdf."},{"key":"15639_CR4","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1200\/JCO.21.00934","volume":"39","author":"M Brackstone","year":"2021","unstructured":"Brackstone M, Baldassarre FG, Perera FE, et al. Management of the axilla in early-stage breast cancer: ontario health (cancer care ontario) and ASCO guideline. J Clin Oncol. 2021;39:3056\u201382.","journal-title":"J Clin Oncol"},{"key":"15639_CR5","unstructured":"American Society of Breast Surgeons Consensus Statement on axillary management for patients with in-situ and invasive breast cancer: concise overview [Internet] [cited 2024 Apr 16] Available at: https:\/\/www.breastsurgeons.org\/docs\/statements\/management-of-the-axilla.pdf."},{"key":"15639_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jss.2023.04.002","volume":"290","author":"AE Li","year":"2023","unstructured":"Li AE, Jhawar S, Grignol V, et al. Implementation of a breast intraoperative oncoplastic form to aid management of oncoplastic surgery. J Surg Res. 2023;290:9\u201315.","journal-title":"J Surg Res"},{"key":"15639_CR7","unstructured":"Breast Cancer [Internet]. NCCN Clinical Practice Guidelines in Oncology, 2024[cited 2024 Mar 19] Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf."},{"key":"15639_CR8","unstructured":"NCCN Guidelines Breast Cancer Risk Reduction Version 1.2023 [Internet]. NCCN [cited 2023 Apr 9] Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail."},{"key":"15639_CR9","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","volume":"31","author":"KS Hughes","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382\u20137.","journal-title":"J Clin Oncol"},{"key":"15639_CR10","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1056\/NEJMoa2302344","volume":"389","author":"TJ Whelan","year":"2023","unstructured":"Whelan TJ, Smith S, Parpia S, et al. Omitting radiotherapy after breast-conserving surgery in luminal A breast cancer. N Engl J Med. 2023;389:612\u20139.","journal-title":"N Engl J Med"},{"key":"15639_CR11","doi-asserted-by":"publisher","first-page":"TPS613","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS613","volume":"40","author":"JR White","year":"2022","unstructured":"White JR, Anderson SJ, Harris EE, et al. NRG-BR007: a phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, hormone receptor+, HER2\u2212, RS \u226418 breast cancer. J Clin Oncol. 2022;40:TPS613.","journal-title":"J Clin Oncol"},{"key":"15639_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1470-2045(21)00080-2","volume":"22","author":"R Orecchia","year":"2021","unstructured":"Orecchia R, Veronesi U, Maisonneuve P, et al. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol. 2021;22:597\u2013608.","journal-title":"Lancet Oncol"},{"key":"15639_CR13","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1016\/j.clbc.2021.05.015","volume":"22","author":"NLV Cernusco","year":"2022","unstructured":"Cernusco NLV, Bianco PD, Romano M, et al. Long-term outcomes using electron IOERT APBI for early stage breast cancer: the verona university hospital experience. Clin Breast Cancer. 2022;22:e167\u201372.","journal-title":"Clin Breast Cancer"},{"key":"15639_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ijrobp.2022.03.010","volume":"113","author":"DHM Jacobs","year":"2022","unstructured":"Jacobs DHM, Mast ME, Horeweg N, et al. Accelerated partial breast irradiation using external beam or intraoperative electron radiation therapy: 5-year oncological outcomes of a prospective cohort study. Int J Radiat Oncol Biol Phys. 2022;113:570\u201381.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15639_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","volume":"383","author":"JS Vaidya","year":"2014","unstructured":"Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383:603\u201313.","journal-title":"Lancet"},{"key":"15639_CR16","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s12094-022-02823-w","volume":"24","author":"M Laplana","year":"2022","unstructured":"Laplana M, Garc\u00eda-Marqueta M, S\u00e1nchez-Fern\u00e1ndez JJ, et al. Effectiveness and safety of intraoperative radiotherapy (IORT) with low-energy x-rays (INTRABEAM\u00ae) for accelerated partial breast irradiation (APBI). Clin Transl Oncol. 2022;24:1732\u201343.","journal-title":"Clin Transl Oncol"},{"key":"15639_CR17","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.clbc.2021.05.002","volume":"22","author":"SO Guillerm","year":"2022","unstructured":"Guillerm SO, Bourstyn E, Itti R, et al. Intraoperative radiotherapy for breast cancer in elderly women. Clin Breast Cancer. 2022;22:e109\u201313.","journal-title":"Clin Breast Cancer"},{"key":"15639_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00520-019-04820-2","volume":"28","author":"PA Williams","year":"2020","unstructured":"Williams PA, Cao S, Yang D, et al. Patient-reported outcomes of the relative severity of side effects from cancer radiotherapy. Support Care Cancer. 2020;28:309\u201316.","journal-title":"Support Care Cancer"},{"key":"15639_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijrobp.2016.04.024","volume":"96","author":"T Corica","year":"2016","unstructured":"Corica T, Nowak AK, Saunders CM, et al. Cosmesis and breast-related quality of life outcomes after intraoperative radiation therapy for early breast cancer: a substudy of the TARGIT-A trial. Int J Radiat Oncol Biol Phys. 2016;96:55\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15639_CR20","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395:1613\u201326.","journal-title":"Lancet"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15639-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15639-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15639-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T18:29:00Z","timestamp":1722882540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15639-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,13]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["15639"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15639-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,13]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Andrea V. Barrio reports speaker honorarium, Novartis; Dr. Oluwadamilola M. Fayanju reports research support outside the current work from Gilead Sciences, Inc.; Dr. Anna Weiss, MD, reports advisory board member\/consult payments, Merck, Myriad, Abbvie. There are no other disclosures to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}